STOCK TITAN
  1. Home
  2. Financials
  3. CSDX

CS Diagnostics Financials

CSDX
Source SEC Filings (10-K/10-Q) Data as of Sep 30, 2025 Currency USD FYE December

This page shows CS Diagnostics (CSDX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial health score pending refresh

We are recalculating CS Diagnostics's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
N/A
EBITDA
N/A
Net Income
$761

CS Diagnostics reported $761 in net income in fiscal year 2025.

EPS (Diluted)
N/A

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$501

CS Diagnostics held $501 in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
137M

CS Diagnostics had 137M shares outstanding in fiscal year 2025.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
0.0%

CS Diagnostics's ROE was 0.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

CSDX Income Statement

Metric Q3'25 Q4'24 Q3'24
Revenue $23K N/A $8K
Cost of Revenue N/A N/A N/A
Gross Profit N/A N/A N/A
R&D Expenses $0 N/A N/A
SG&A Expenses $70 N/A $70
Operating Income -$182 N/A $536
Interest Expense N/A N/A N/A
Income Tax N/A N/A N/A
Net Income -$182 N/A $536
EPS (Diluted) $0.00 N/A $0.00

CSDX Balance Sheet

Metric Q3'25 Q4'24 Q3'24
Total Assets $499.4M0.0% $499.4M N/A
Current Assets $31K+6090.2% $501 N/A
Cash & Equivalents $13-97.4% $501-98.8% $42K
Inventory N/A N/A N/A
Accounts Receivable N/A N/A N/A
Goodwill N/A N/A N/A
Total Liabilities $2K+12.7% $1K N/A
Current Liabilities N/A N/A N/A
Long-Term Debt N/A N/A N/A
Total Equity $499.4M0.0% $499.4M N/A
Retained Earnings -$4.7M+0.7% -$4.8M N/A

CSDX Financial Ratios

Metric Q3'25 Q4'24 Q3'24
Gross Margin N/A N/A N/A
Operating Margin -0.8% N/A 6.7%
Net Margin -0.8% N/A 6.7%
Return on Equity 0.0% N/A N/A
Return on Assets 0.0% N/A N/A
Current Ratio N/A N/A N/A
Debt-to-Equity 0.000.0 0.00 N/A
FCF Margin N/A N/A N/A

Similar Companies

Guided Thera GTHP
$25.1M
Biotricity Inc BTCY
$14.3M
Perimeter Medical Imaging Ai Inc PYNKF
$33.1M
Aurora Spine ASAPF
$12.2M
PharmChem, Inc. PCHM
$17.3M

Frequently Asked Questions

Yes, CS Diagnostics (CSDX) reported a net income of $761 in fiscal year 2025.

CS Diagnostics (CSDX) has a return on equity of 0.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

CS Diagnostics (CSDX) had $499.4M in total assets as of fiscal year 2025, including both current and long-term assets.

CS Diagnostics (CSDX) had 137M shares outstanding as of fiscal year 2025.

CS Diagnostics (CSDX) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

CS Diagnostics (CSDX) had a return on assets of 0.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Back to top